IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses

Clinical Immunology

Volumn 143, Issue 3, 2012, Pages 236-245

  Fania, Luca ^a,b   Caldarola, Giacomo ^b,c   Müller, Ralf ^a   Brandt, Oliver ^a   Pellicano, Riccardo ^c   Feliciani, Claudio ^b   Hertl, Michael ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b CATHOLIC UNIVERSITY   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

BP180; BP230; Bullous pemphigoid; Hemidesmosome; IgE; Pruritus

Indexed keywords

BULLOUS PEMPHIGOID 180 PROTEIN; BULLOUS PEMPHIGOID 180 PROTEIN ANTIBODY; BULLOUS PEMPHIGOID ANTIGEN 1; BULLOUS PEMPHIGOID ANTIGEN 1 ANTIBODY; COLLAGEN; COLLAGEN ANTIBODY; EPITOPE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ALLERGY; AMINO TERMINAL SEQUENCE; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; BULLOUS PEMPHIGOID; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DOMAIN; PRURITUS;

AGED; AUTOANTIBODIES; AUTOANTIGENS; EPITOPES; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; PRURITUS;

EID: 84861231406     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.02.003     Document Type: Article

References (37)

1. Di Zenzo G., Marazza G., Borradori L. Bullous pemphigoid: physiopathology, clinical features and management. Adv. Dermatol. 2007, 23:257-288.
2. Di Zenzo G., Laffitte E., Zambruno G., Borradori L. Bullous pemphigoid: clinical features, diagnostic markers and immunopathogenic mechanisms. Autoimmune Diseases of the Skin 2011, 65-96. Springer Verlag, Wien-New York. 3rd ed. M. Hertl (Ed.).
3. Lamb P.M., Abell E., Tharp M., Frye R., Deng J.S. Prodromal bullous pemphigoid. Int. J. Dermatol. 2006, 45:209-214.
4. Feliciani C., Caldarola G., Kneisel A., Podstawa E., Pfütze M., Pfützner W., Hertl M. IgG autoantibody reactivity against BP180 and BP230 in elderly patients with pruritic dermatoses. Br. J. Dermatol. 2009, 161:306-312.
5. Stanley J.R., Hawley-Nelson P., Yuspa S.H., Shevach E.M., Katz S.I. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 1981, 24:897-903.
6. Labib R.S., Anhalt G.J., Patel H.P., Mutasim D.F., Diaz L.A. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J. Immunol. 1986, 136:1231-1235.
7. Giudice G.J., Emery D.J., Diaz L.A. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J. Invest. Dermatol. 1992, 99:243-250.
8. Di Zenzo G., Thoma-Uszynski S., Fontao L., Calabresi V., Hofmann S.C., Hellmark T., Sebbag N., Pedicelli C., Sera F., Lacour J.P., Wieslander J., Bruckner-Tuderman L., Borradori L., Zambruno G., Hertl M. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clin. Immunol. 2008, 128:415-426.
9. Skaria M., Jaunin F., Hunziker T., Riou S., Schumann H., Bruckner-Tuderman L., Hertl M., Bernard P., Saurat J.H., Favre B., Borradori L. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomain of the COOH terminus of BP230. J. Invest. Dermatol. 2000, 114:998-1004.
10. Zillikens D., Mascaro J.M., Rose P.A., Liu Z., Ewing S.M., Caux F., Hoffmann R.G., Diaz L.A., Giudice G.J. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J. Invest. Dermatol. 1997, 109:679-683.
11. Thoma-Uszynski S., Uter W., Schwietzke S., Schuler G., Borradori L., Hertl M. Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230. J. Immunol. 2006, 176:2015-2023.
12. Nishie W., Sawamura D., Goto M., Ito K., Shibaki A., McMillan J.R., Sakai K., Nakamura H., Olasz E., Yancey K.B., Akiyama M., Shimizu H. Humanization of autoantigen. Nat. Med. 2007 Mar, 13(3):378-383. Epub 2007 Feb 25.
13. Heimbach L., Li N., Diaz A., Liu Z. Experimental animal models of bullous pemphigoid. G. Ital. Dermatol. Venereol. 2009 Aug, 144(4):423-431.
14. Dvorak A.M., Jr Mihm M.C., Osage J.E., Kwan T.H., Austen K.F., Wintroub B.U. Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. J. Invest. Dermatol. 1982, 78:91-101.
15. Nishioka K., Hashimoto K., Katayama I., Sarashi C., Kubo T., Sano S. Eosinophilic spongiosis in bullous pemphigoid. Arch. Dermatol. 1984, 120:1166-1168.
16. Guo J., Rapoport B., McLachlan S.M. Thyroid peroxidase autoantibodies of IgE class in thyroid autoimmunity. Clin. Immunol. Immunopathol. 1997, 82:157-162.
17. Sato A., Takemura Y., Yamada T., Ohtsuka H., Sakai H., Miyahara Y., Aizawa T., Terao A., Onuma S., Junen K., Kanamori A., Nakamura Y., Tejima E., Ito Y., Kamijo K. A possible role of immunoglobulin E in patients with hyperthyroid Graves' disease. J. Clin. Endocrinol. Metab. 1999, 84:3602-3605.
18. Nagel A., Lang A., Engel D., Podstawa E., Hunzelmann N., De Pità O., Borradori L., Uter W., Hertl M. Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3. Clin. Immunol. 2010, 134:320-330.
19. Leighty L., Li N., Diaz L.A., Liu Z. Experimental models for the autoimmune and inflammatory blistering disease, bullous pemphigoid. Arch. Dermatol. Res. 2007, 299:417-422.
20. Zone J.J., Taylor T., Hull C., Schmidt L., Meyer L. IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice. J. Invest. Dermatol. 2007, 127:1167-1174.
21. Fairley J.A., Burnett C.T., Fu C.L., Larson D.L., Fleming M.G., Giudice G.J. A pathogenic role for IgE in autoimmunity: bullous pempigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice. J. Invest. Dermatol. 2007, 127:2605-2611.
22. Asbrink E., Hovmark A. Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies. Acta Derm. Venereol. 1984, 64:243-246.
23. Delaporte E., Dubost-Brama A., Ghohestani R., Nicolas J.F., Neyrinck J.L., Bergoend H., Janin A., Capron M. IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid. J. Immunol. 1996, 157:3642-3647.
24. Ghohestani R.F., Cozzani E., Delaporte E., Nicolas J.F., Parodi A., Claudy A. IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230). J. Clin. Immunol. 1998, 18:202-209.
25. Ishiura N., Fujimoto M., Watanabe R., Nakashima H., Kuwano Y., Yazawa N., Echigo T., Okochi H., Tamaki K. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. J. Dermatol. Sci. 2008, 49:153-161.
26. Dimson O.G., Giudice G.J., Fu C.L., Van den Bergh F., Warren S.J., Janson M.M., Fairley J.A. Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid. J. Invest. Dermatol. 2003, 120:784-788.
27. Fairley J.A., Fu C.L., Giudice G.J. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid. J. Invest. Dermatol. 2005, 125:467-472.
28. Hofmann S., Thoma-Uszynski S., Hunziker T., Bernard P., Koebnick C., Stauber A., Schuler G., Borradori L., Hertl M. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH terminal regions of the BP180 ectodomain. J. Invest. Dermatol. 2002, 119:1065-1073.
29. Döpp R., Schmidt E., Chimanovitch I., Leverkus M., Bröcker E.B., Zillikens D. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J. Am. Acad. Dermatol. 2000, 42:577-583.
30. Dresow S.K., Sitaru C., Recke A., Oostingh G.J., Zillikens D., Gibbs B.F. IgE autoantibodies against the intracellular domain of BP180. Br. J. Dermatol. 2009, 160:429-432.
31. Thoma-Uszynsk S., Uter W., Schwietzke S., Hofmann S.C., Hunziker T., Bernard P., Treudler R., Zouboulis C.C., Schuler G., Borradori L., Hertl M. BP230- and BP180-specific auto-antibodies in bullous pemphigoid. J. Invest. Dermatol. 2004, 122:1413-1422.
32. Haase C., Büdinger L., Borradori L., Yee C., Merk H.F., Yancey K., Hertl M. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2. J. Invest. Dermatol. 1998, 110:282-286.
33. Kaminska R., Helisalmi P., Harvima R.J., Naukkarinen A., Horsmanheimo M., Harvima I.T. Focal dermal-epidermal separation and fibronectin cleavage in basement membrane by human mast cell tryptase. J. Invest. Dermatol. 1999, 113:567-573.
34. Jedlickova H., Racovska J., Niedermeier A., Feit J., Hertl M. Anti-basement membrane zone antibodies in elderly patients with pruritic disorders and diabetes mellitus. Eur. J. Dermatol. 2008, 18:534-538.
35. Yayli S., Pelivani N., Beltraminelli H., Wirthmüller U., Bekeznay Z., Horn M., Borradori L. Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis. Br. J. Dermatol. 2011, 165:1133-1137.
36. Fairley J.A., Baum C.L., Brandt D.S., Messingham K.A.N. Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab. J. Allergy Clin. Immunol. 2009, 123:704-705.
37. Di Zenzo G., Thoma-Uszynski S., Calabresi V., Fontao L., Hofmann S.C., Lacour J.P., Sera F., Bruckner-Tuderman L., Zambruno G., Borradori L., Hertl M. J. Invest. Dermatol. 2011, 131:2271-2280.